Beam Therapeutics Inc (BEAM)
21.76
+0.54
(+2.54%)
USD |
NASDAQ |
May 01, 16:00
21.76
0.00 (0.00%)
After-Hours: 20:00
Beam Therapeutics 1 Year Total Returns (Daily): -30.90% for April 30, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 30, 2024 | -30.90% |
April 29, 2024 | -28.20% |
April 26, 2024 | -30.02% |
April 25, 2024 | -29.04% |
April 24, 2024 | -25.47% |
April 23, 2024 | -24.68% |
April 22, 2024 | -22.66% |
April 19, 2024 | -23.98% |
April 18, 2024 | -21.83% |
April 17, 2024 | -23.67% |
April 16, 2024 | -17.81% |
April 15, 2024 | -17.81% |
April 12, 2024 | -12.84% |
April 11, 2024 | -9.37% |
April 10, 2024 | -10.07% |
April 09, 2024 | -1.41% |
April 08, 2024 | -3.13% |
April 05, 2024 | -3.82% |
April 04, 2024 | -1.83% |
April 03, 2024 | -1.49% |
April 02, 2024 | -0.23% |
April 01, 2024 | 6.66% |
March 28, 2024 | 9.55% |
March 27, 2024 | 11.20% |
March 26, 2024 | 9.31% |
Date | Value |
---|---|
March 25, 2024 | 10.86% |
March 22, 2024 | 9.65% |
March 21, 2024 | 7.87% |
March 20, 2024 | 8.19% |
March 19, 2024 | 4.88% |
March 18, 2024 | 2.54% |
March 15, 2024 | 0.88% |
March 14, 2024 | 1.38% |
March 13, 2024 | 10.69% |
March 12, 2024 | 11.39% |
March 11, 2024 | 13.78% |
March 08, 2024 | 0.37% |
March 07, 2024 | -1.75% |
March 06, 2024 | 0.39% |
March 05, 2024 | -1.51% |
March 04, 2024 | -2.20% |
March 01, 2024 | 3.48% |
February 29, 2024 | -1.86% |
February 28, 2024 | 8.37% |
February 27, 2024 | 15.59% |
February 26, 2024 | -8.02% |
February 23, 2024 | -16.03% |
February 22, 2024 | -17.83% |
February 21, 2024 | -19.29% |
February 20, 2024 | -26.34% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-70.22%
Minimum
Jul 01 2022
607.2%
Maximum
Mar 16 2021
43.80%
Average
-31.44%
Median
1 Year Total Returns (Daily) Benchmarks
Eli Lilly and Co | 98.95% |
Moderna Inc | -17.01% |
Pfizer Inc | -30.67% |
Editas Medicine Inc | -36.09% |
Intellia Therapeutics Inc | -43.36% |